Fundraising FoxuMed
4 known investors
Find your way into uMed
Sign up to see every warm intro you have to uMed
- Paths you didn't know you had: your email and LinkedIn already hold routes to the uMed team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
uMed provides data and insights infrastructure to accelerate the development and delivery of new medicines by addressing evidence gaps across the therapy lifecycle. The company enables access to clinical research data and patient insights for pharmaceutical companies, researchers, and healthcare institutions developing new treatments.
Investors · 4
How we know: 11.2 Capital's portfolio page · fiercebiotech.com · Not right? Tell us
How we know: AlbionVC's portfolio page · fiercebiotech.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · fiercebiotech.com · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountseed roundDec 2020Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does uMed do?
- uMed provides data and insights infrastructure to accelerate the development and delivery of new medicines by addressing evidence gaps across the therapy lifecycle. The company enables access to clinical research data and patient insights for pharmaceutical companies, researchers, and healthcare institutions developing new treatments.
- Who are uMed's investors?
- uMed's investors include 11.2 Capital, AlbionVC, Delin Ventures, Playfair Capital.